Showing results (1181-1190 of 1,302) with videos related to
Sort By:
Pageof 131
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid TumorsPamela N Munster, Andrew E Greenstein, Gini F Fleming, et al.Urology|August 21, 2023
Surveillance for Nonmuscle Invasive Bladder Cancer: Identifying the Point of Diminishing ReturnsDaniel Ranti, Linda Dey, Christine Bieber, et al.Spine|February 17, 2017
Differences in Short-Term Outcomes Between Primary and Revision Anterior Cervical Discectomy and FusionBryce A Basques, Nathaniel T Ondeck, Erik J Geiger, et al.Journal of Spinal Disorders & Techniques|December 1, 2004
Evaluation of a novel pedicle probe for the placement of thoracic and lumbosacral pedicle screwsJonathan N Grauer, Alexander R Vaccaro, Georgiy Brusovanik, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 26, 2018
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group StudyMichael R McClung, Jacques P Brown, Adolfo Diez-Perez, et al.Theranostics|January 27, 2021
Imaging temozolomide-induced changes in the myeloid glioma microenvironmentClaudia Foray, Silvia Valtorta, Cristina Barca, et al.The Journal of Bone and Joint Surgery. American Volume|January 25, 2020
A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip FracturesEmil H Schemitsch, Theodore Miclau, Theofilos Karachalios, et al.The Lancet. Diabetes & Endocrinology|July 25, 2020
Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trialsDennis M Black, Douglas C Bauer, Eric Vittinghoff, et al.Biochemical and Biophysical Research Communications|April 2, 2017
Impact of antibody subclass and disulfide isoform differences on the biological activity of CD200R and βklotho agonist antibodiesOgnjen Grujic, Jennitte Stevens, Robert Y-T Chou, et al.Spine|April 2, 2008
Variations in surgical treatment of cervical facet dislocationsAhmad Nassr, Joon Y Lee, Marcel F Dvorak, et al.Pageof 131